LNCaP-OM, a new androgen-resistant prostate cancer subline

In Vitro Cellular and Developmental Biology - Animal

Volumn 33, Issue 3, 1997, Pages 147-149

  Platica, M ^a   Verma, R S ^a   Macera, M J ^a   Platica, O ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

CANCER CELL CULTURE; CANCER GROWTH; CANCER PALLIATIVE THERAPY; GROWTH RATE; HORMONE RESISTANCE; HUMAN; HUMAN CELL; LETTER; MALE; METASTASIS; PROSTATE CANCER;

EID: 0030948391     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-997-0131-1     Document Type: Letter

References (12)

1. 1. A. R. Brothman L. J. Lesho K. D. Somers 1989 Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma Int. J. Cancer 44 898 903 2583869 10.1002/ijc.2910440525 1:STN:280:By%2BD287ks1E%3D Brothman, A. R.; Lesho, L. J.; Somers, K. D., et al. Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma. Int. J. Cancer 44:898–903; 1989.
2. 2. T. Deguchi T. Doi H. Ehara 1993 Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase polymerase chain reaction Cancer Res. 53 5350 5354 7693338 1:CAS:528:DyaK2cXpslarug%3D%3D Deguchi, T.; Doi, T.; Ehara, H., et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase polymerase chain reaction. Cancer Res. 53:5350–5354; 1993.
3. 3. J. R. Gingrich J. A. Tucker P. J. Walther 1991 Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1) J. Urol. 146 915 919 1875519 1:STN:280:By6A2c7psVc%3D Gingrich, J. R.; Tucker, J. A.; Walther, P. J., et al. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J. Urol. 146:915–919; 1991.
4. 4. J. S. Horoszewicz S. S. Leong E. Kawinski 1983 LNCaP model of human prostatic carcinoma Cancer Res. 43 1809 1818 6831420 1:CAS:528:DyaL3sXhsFylsLg%3D Horoszewicz, J. S.; Leong, S. S.; Kawinski, E., et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1809–1818; 1983.
5. 5. M. E. Kaighn K. S. Narayan Y. Ohnuki 1979 Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest. Urol. 17 16 23 447482 1:STN:280:CSaC1Mzms1Q%3D Kaighn, M. E.; Narayan, K. S.; Ohnuki, Y., et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 17:16–23; 1979.
6. 6. J. J. Konig E. Kamst A. Hagemeijer 1989 Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP Urol. Res. 17 79 86 2734981 10.1007/BF00262025 1:STN:280:BiaB1cvkt10%3D Konig, J. J.; Kamst, E.; Hagemeijer, A., et al. Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol. Res. 17:79–86; 1989.
7. 7. M. R. Smith S. Bigger M. Hussain 1995 Prostate specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases Cancer Res. 55 2640 2644 7540108 1:CAS:528:DyaK2MXmtlWrt74%3D Smith, M. R.; Bigger, S.; Hussain, M. Prostate specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res. 55:2640–2644; 1995.
8. 8. K. R. Stone D. D. Mickey H. Wunderli 1978 Isolation of a human prostate carcinoma cell line (DU 145) Int. J. Cancer 21 274 281 631930 10.1002/ijc.2910210305 1:STN:280:CSeC38bitVY%3D Stone, K. R.; Mickey, D. D.; Wunderli, H., et al. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21:274–281; 1978.
9. 9. W. D. Tilley C. M. Wilson M. Marcelli 1990 Androgen receptor gene expression in human prostate carcinoma cell lines Cancer Res. 50 5382 5386 2386943 1:CAS:528:DyaK3cXlsV2kurg%3D Tilley, W. D.; Wilson, C. M.; Marcelli, M., et al. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50:5382–5386; 1990.
10. 10. G. J. Steenbrugge van M. Groen J. W. Dongen van 1989 The human prostatic carcinoma cell line LNCaP and its derivatives. An overview Urol. Res. 17 71 77 2660395 10.1007/BF00262024 van Steenbrugge, G. J.; Groen, M.; van Dongen, J. W., et al. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview. Urol. Res. 17:71–77; 1989.
11. 11. G. J. Steenbrugge van C. J. C. Uffelen Van J. Bolt 1991 The human prostatic cancer cell line LNCaP and its derived sublines an in vitro model for the study of androgen sensitivity J. Steroid Biochem. Mol. Biol. 40 207 214 1958522 10.1016/0960-0760(91)90184-7 van Steenbrugge, G. J.; Van Uffelen, C. J. C.; Bolt, J., et al. The human prostatic cancer cell line LNCaP and its derived sublines an in vitro model for the study of androgen sensitivity. J. Steroid Biochem. Mol. Biol. 40:207–214; 1991.
12. 12. R. S. Verma A. Babu 1995 Human chromosomes: principles and techniques McGraw Hill New York Verma, R. S.; Babu, A. Human chromosomes: principles and techniques. New York: McGraw Hill; 1995.